You are here

Sosei Heptares

Pfizer advances diabetes, obesity drug hopeful into mid-stage testing

Pfizer advances diabetes, obesity drug hopeful into mid-stage testing

BioPharma Dive

Flag link:

AbbVie gives Sosei a StaRring role in neurological drug discovery plans, paying $40M and committing $1.2B

AbbVie gives Sosei a StaRring role in neurological drug discovery plans, paying $40M and committing $1.2B

Fierce Biotech

neurological disorders

Flag link:

GlaxoSmithKline joins Sosei's who's-who list of clients with global licensing pact for IBD small molecules

GlaxoSmithKline joins Sosei's who's-who list of clients with global licensing pact for IBD small molecules

Endpoints

inflammatory bowel disease

Flag link:

Sosei pens inflammatory and autoimmune disease drug pact with AbbVie

Sosei pens inflammatory and autoimmune disease drug pact with AbbVie

Fierce Biotech

Flag link:

Takeda, Sosei form gastrointestinal disease R&D pact

Takeda, Sosei form gastrointestinal disease R&D pact

Fierce Biotech

gastrointestinal disease

Flag link:

Roche's Genentech goes on deal spree, unveiling third deal on the same day

Roche's Genentech goes on deal spree, unveiling third deal on the same day

Endpoints

Skyhawk Therapeutics

Convelo Therapeutics

Flag link:

Pfizer selects first GPCR candidate from Sosei Heptares tie-up

Pfizer selects first GPCR candidate from Sosei Heptares tie-up

Pharmaforum

drug development

Flag link: